An Extended Follow-up Study of the HPV Vaccine Delayed Booster Trial

Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease (NAFLD)

A Randomized and Placebo-Controlled Phase II Trial Targeting Dominant-Negative Missense Mutant p53 by Atorvastatin for Reducing the Risk of Longstanding Ulcerative Colitis-Associated Cancer

Surgical Window of Opportunity Study of Megesterol Acetate and Metformin for Endometrial Intraepithelial Neoplasia

Clinical Study of Bioactivity of Low Dose Apalutamide in Prostate Cancer Patients Scheduled for Prostatectomy

A Phase IIa, Placebo-Controlled, Randomized Study of Daily Obeticholic Acid (OCA) to Reduce Intestinal Polyp Burden in Familial Adenomatous Polyposis (FAP)

Time Restricted Eating and Metformin (TEAM) in Breast Cancer (BC) and Adjacent Intraepithelial Neoplasia (IEN). A Randomized, Phase IIb, Window of Opportunity PreSurgical Trial

A Phase II Trial of the Immunogenicity of a DNA Plasmid Based Vaccine (STEMVAC) Encoding Th1 Selective Epitopes from Five Antigens Associated with Breast Cancer Stem Cells (MDM2, YB1, SOX2, CDC25B, CD105) in Patients with Early Stage Triple Negative Breast Cancer

Metformin for Chemoprevention of Lung Cancer in High Risk Obese Patients

Obeticholic Acid for Chemoprevention in Barrett’s Esophagus

A Phase II Clinical Trial of the Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury) Vaccine (Tri-Ad5) in Lynch syndrome

A Dose Escalation Phase I Trial of the Safety and Immunogenicity of RG1-VLP, A Candidate Broadly Protective Vaccine for the Prevention of HPV-Associated Cancer

Pilot Study of GCC Agonists to Identify A Cyclic-GMP Signal in Duodenal Tissue of Healthy Volunteers

Phase II Randomized, Placebo-Controlled Trial of Broccoli Seed and Sprout Extract (BSSE) to Evaluate Sustained Detoxication of Tobacco Carcinogens in Heavy Smokers (BSSE)

A Phase Ib Clinical Trial of Nous-209 for Recurrent Neoantigen Immunogenicity and Cancer Immune Interception in Lynch Syndrome Patients

M4OC-Prevent 2.0: Phase IIb Trial of Metformin for Oral Cancer Prevention

A Phase II Trial of Oral Iloprost for the Precision Chemoprevention of Lung Cancer

ONC201 for Chemoprevention in Colorectal Cancer (BrUOG 399)

Randomized Trial of Apalutamide in Non-Muscle Invasive Bladder Cancer

Phase IIA Trial of Acolbifene (20 mg) vs Low Dose Tamoxifen (5 mg) in Pre-menopausal Women at High Risk for Development of Breast Cancer

Calcipotriol plus 5-fluorouracil Immunotherapy for Skin Cancer Prevention in Organ Transplant Recipients

Randomized, Placebo-Controlled Trial of Broccoli Seed and Sprout Extract (BSSE) to Evaluate Detoxification of Carcinogens in Firefighters

A Phase II Placebo-Controlled Trial of Urolithin A Supplementation In Men With Prostate Cancer Undergoing Radical Prostatectomy

A Phase 0 Trial of Omeprazole and Low Dose Aspirin to Identify Pharmacodynamic Biomarkers of Preventive Efficacy in the Colon

Refining Tamoxifen Dose for Premenopausal Breast Cancer Prevention (RENAISSANCE): A Phase II Single Arm Trial

Phase 2 Study of Low Dose Tamoxifen +/-High Dose EPA & DHA Omega-3 Fatty Acids in Obese Postmenopausal Women at Increased Risk for Breast Cancer

Phase 1a Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)

Phase 2 Study to Evaluate the Safety and Efficacy of TPST-1495 in Patients with Familial Adenomatous Polyposis (FAP)

Repurposing Itraconazole for Secondary Prevention of Metaplasia and Primary Prevention of Cancer in Patients with High-risk Barrett’s Esophagus after Ablation

Evaluating the Feasibility of a Survivin Peptide Vaccine (SurVaxM) as an Interception Agent in Patients at High Risk for Lung Cancer